Get the Stockscreener App
13.01
3.63%
-0.49
Abrdn Life Sciences Investors stock is traded at $13.01, with a volume of 209.96K.
It is down -3.63% in the last 24 hours and up +3.42% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$13.50
Open:
$13.38
24h Volume:
209.96K
Relative Volume:
1.87
Market Cap:
$375.63M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.61%
1M Performance:
+3.42%
6M Performance:
-5.45%
1Y Performance:
-14.97%
1-Day Range:
$13.01
$13.40
1-Week Range:
$12.87
$13.50
52-Week Range:
$10.55
$15.90
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
13.01 | 377.94M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.81 | 3.59B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
37.27 | 3.26B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
21.95 | 2.55B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
26.56 | 2.59B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.65 | 2.47B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Is Abrdn Healthcare Investors a good long term investmentFree Stock Market Forecast Reports - Autocar Professional
What analysts say about Abrdn Life Sciences Investors stockDynamic portfolio growth - Autocar Professional
What drives Abrdn Healthcare Investors stock priceFree Predictions - Autocar Professional
Stephens Inc. AR Purchases 6,947 Shares of abrdn Life Sciences Investors (NYSE:HQL) - Defense World
Is Abrdn Life Sciences Investors a good long term investmentAccelerated financial growth - Autocar Professional
Formidable Asset Management LLC Takes $812,000 Position in abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
What drives Abrdn Life Sciences Investors stock priceHigh-profit trading signals - Autocar Professional
Abrdn Healthcare Investors Stock Analysis and ForecastBreakneck growth rates - jammulinksnews.com
What drives SBA Communications Corporation stock priceRapidly growing investment returns - jammulinksnews.com
What analysts say about Abrdn Healthcare Investors stockDynamic growth stocks - jammulinksnews.com
What drives XPEV stock priceSkyrocketing profit margins - jammulinksnews.com
Abrdn Life Sciences Investors Stock Analysis and ForecastTriple-digit profit margins - jammulinksnews.com
UPL Limited (890209) Expands into New MarketPhenomenal wealth increase - Jammu Links News
Verve Therapeutics Inc. Stock Analysis and ForecastAccelerated profit realization - Jammu Links News
Most Promising Indian Stocks Smart Investment TechniquesLightning-fast capital gains - Jammu Links News
abrdn Healthcare Investors To Go Ex-Dividend On February 21st, 2024 With 0.48 USD Dividend Per Share - 富途牛牛
Does Abrdn Healthcare Investors stock pay reliable dividendsFree Capital Growth Strategies - Newser
abrdn Life Sciences Investors (NYSE:HQL) Shares Purchased by Stratos Wealth Partners LTD. - Defense World
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Trading Up 0.9% – Should You Buy? - Defense World
QTES(qtes) Price ForecastBreakout Setup Scanner - Newser
How MVST stock performs during market volatilityMoney Making Low Risk Plans - Newser
How Abrdn Life Sciences Investors stock performs during market volatilityProven High Yield Signals - Newser
How Helionetics Inc. Preferred Security stock performs during market volatilityTrade Ready Signal - Newser
What makes Abrdn Life Sciences Investors stock price move sharplySafe Entry High Exit Alerts - Newser
Why Abrdn Life Sciences Investors stock attracts strong analyst attentionConsistent Win Signals - Newser
How Abrdn Healthcare Investors stock performs during market volatilitySecure Growth Trading Plan - Newser
Why Abrdn Healthcare Investors stock attracts strong analyst attentionMassive Gain Ideas - Newser
How The Shyft Group Inc. stock performs during market volatilityTop Analyst Picks - Newser
What makes Abrdn Healthcare Investors stock price move sharplySmart High Yield Swing Trades - Newser
What makes Sonoma Pharmaceuticals Inc. stock price move sharplyFree Deep Market Trend Analysis - Newser
Why RGLD stock attracts strong analyst attentionShort Term High Return Strategy - Newser
Why PSA.PRS stock attracts strong analyst attentionTargeted 200 Percent Gain - Newser
How Citizens Inc. stock performs during market volatilityFree Consultation - Newser
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.60%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):